SPONSOR
Helse Stavanger HF
Total Trials
5
Recruiting
5
Phases
Phase 2
Conditions studied: Cognitive Decline, MildAlzheimer DiseaseDementia AlzheimersAnxiety DisordersBreast CancerChronic Fatigue SyndromeIBD
Helse Stavanger HF is a clinical research sponsor with 5 registered studies on ClinicalTrials.gov, of which 5 are actively recruiting participants. Research covers conditions including Cognitive Decline, Mild, Alzheimer Disease, Dementia Alzheimers, Anxiety Disorders.
The trial portfolio spans Phase 2 studies, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.
Frequently Asked Questions — Helse Stavanger HF
How many clinical trials has Helse Stavanger HF sponsored?
ClinicalMetric currently tracks 5 clinical trials sponsored by Helse Stavanger HF, of which 5 are actively recruiting participants. These trials cover conditions including Cognitive Decline, Mild, Alzheimer Disease, Dementia Alzheimers. Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.
What therapeutic areas does Helse Stavanger HF research focus on?
Helse Stavanger HF clinical trials span Cognitive Decline, Mild, Alzheimer Disease, Dementia Alzheimers, Anxiety Disorders, Breast Cancer, and additional conditions. The research pipeline includes Phase 2 trials, reflecting work from early-stage safety evaluation through large-scale efficacy studies.
How do I participate in a Helse Stavanger HF clinical trial?
To participate in a Helse Stavanger HF trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all Helse Stavanger HF trials with current recruitment status updated daily.
Clinical Trials by Helse Stavanger HF
NCT06362707 Phase 2
Recruiting
Fasudil Trial for Treatment of Early Alzheimer's Disease (FEAD)
Cognitive Decline, Mild
NCT05187819
Recruiting
Blood-based Biomarkers for Diagnosis of Alzheimer's
Dementia Alzheimers
NCT07145307
Recruiting
Personalized Digital Treatment for Adolescent Anxiety: A Feasibility Trial
Anxiety Disorders
NCT05587777
Recruiting
Monitoring of Chronic Conditions in Breast Cancer
Breast Cancer
NCT01551563
Recruiting
Stavanger University Hospital Inflammatory Bowel Disease Trial
IBD
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: April 2026 · Data Methodology